CompletedNot Applicable

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer. (KDOGCOV)

France35 participantsStarted 2021-01-25

Plain-language summary

To ascertain the possibilities to isolate the breast cancer olfactive signature

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patient received in surgery consultation for an invasive non metastatic breast cancer treated by breast-conserving surgery with axillary or sentinel node dissection
✓. Of-Age female patient (over 18 years old)
✓. Life expectancy \> to 1 year at the inclusion
✓. ECOG performance status: 0 or 1 or 2
✓. Patient benefiting from the social security
✓. Signature informed consent of the study

✕. Neoplasia in progress or neoplasia history of cancer other than breast to be treated.
✕. Wound presence on breasts
✕. Male subjects
✕. Pregnant or lactating women
✕. Specified metastatic breast cancer
✕. Concomitant medication taken one month before the surgical act (antibiotics, corticoids, anti-diabetics)
✕. Persons under guardianship or deprived of liberty
✕. Impossibility to submit to the medical monitoring expected by the study for geographical, social or psychological reasons.

To ascertain the possibilities to isolate the breast cancer olfactive signature

Timeframe: 18 months

NCT IDNCT04541537

SponsorInstitut Curie

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-09